Investor Presentaiton

Biologic Drugs are the Primary Growth Driver Within Injectables Market Segment Biopharmaceutical Injectables In-Vitro Diagnostics End Market Biologics Vaccines Insulin Small Molecules & Generics Molecular Diagnostic Other Market Volume Growth¹ 15%+ 6% to 8% 1% to 2% ~2% ~10% ~6% 2022-27 CAGR GLP-1 Antibodies & Proteins mRNA LDD² LDD2 Sub-segment Volume Growth HDD2 SG, Stevanato Group 1Source: IQVIA, Alira Health 2 LDD: Low double-digit HDD: High double-digit Bulk of the current market Stevanato Group Investor Presentation, March 2024 Cell & Gene Therapies HDD2 18

View entire presentation